1.Traditional uses, phytochemistry and pharmacology of Tecomella undulata- A review
Jain Mahendra ; Kapadia Rakhee ; Jadeja Navalsinh Ravirajsinh ; Thounaojam Chanu Menaka ; Devkar Vijaysinh Ranjitsinh ; Mishra Hari Shri
Asian Pacific Journal of Tropical Biomedicine 2012;(z3):1918-1923
The aim of the present review is to present comprehensive information of the traditional uses, phytochemistry and pharmacology of Tecomella undulata (Family, Bignoniaceae) and to discuss future scope of research. Tecomella undulata (TU) is commonly known as desert teak (ver. Rohiro) and is traditionally for treating liver and spleen diseases, tumours, conjunctivitis, hepatosplenomegaly, syphilis, gonorrhea, hepatitis, as a blood purifier and in wound healing. Compounds such as naphthaquinone derivative, iridoid glucoside, phytosterol, fatty alcohol, flavonols, flavonoid glucoside and triterpenoids have been reported from TU. Anti HIV, anti bacterial, anti microbial, immune modulator, analgesic and hepatoprotective activities have been reported from its various aerial parts. In the present review, attempts have been made to compile research reports on TU, to assess current research trends with possible future avenues of research.
2.Cytotoxicity evaluation and hepatoprotective potential of bioassay guided fractions from Feronia Limmonia Linn leaf.
Mahendra JAIN ; Rakhee KAPADIA ; Ravirajsinh N JADEJA ; Menaka C THOUNAOJAM ; Ranjitsinh V DEVKAR ; S H MISHRA
Asian Pacific Journal of Tropical Biomedicine 2011;1(6):443-447
OBJECTIVETo evaluate the cytotoxicity and hepatoprotective potentials of extracts, fractions or isolated compound from the leaves of Feronia limonia (F. limonia).
METHODSQualitative phytochemical analysis of extracts, fractions or compound was performed by means of thin layer chromatography and spectroscopic assays. The % purity of compound was measured by analytical HPLC. Extracts, fractions or compound have been individually evaluated for their cytotoxicity effects (10, 20, 100, 250, 500, 750 and 1 000 µg/mL). Based on the inhibitory concentration (IC50) obtained from the cell viability assay, graded concentrations of extracts, fractions or isolated compound were assessed (10, 20, 50, 100, 200 µg/mL) for its hepatoprotective potential against CCl4-induced hepatotoxicity by monitoring activity levels of serum glutamatic pyruvatic transaminase (SGPT) and serum glutamic oxaloacetic transaminase (SGOT).
RESULTSResults indicated that the methanol extract of F. limonia was non-toxic and hepatoprotective in nature as compared with the petroleum ether extract. The acetone fraction of methanolic extract also showed similar properties but the subsequent two fractions were cytotoxic. However, the pure compound isolated from the penultimate fraction of methanolic extract was non-toxic and hepatoprotective in nature. Biochemical investigations (SGOT, SGPT) further corroborated these cytological observations.
CONCLUSIONSIt can be concluded from this study that F. limonia methanol extract, some fractions and pure isolated compound herein exhibit hepatoprotective activity. However, cytotoxicity recorded in the penultimate fraction and investigation of structural details of pure compound warrants further study.
Biological Assay ; Cell Survival ; drug effects ; Chromatography, Thin Layer ; Gastrointestinal Agents ; isolation & purification ; pharmacology ; Humans ; Inhibitory Concentration 50 ; Liver ; drug effects ; Phytochemicals ; isolation & purification ; pharmacology ; Plant Leaves ; chemistry ; Rutaceae ; chemistry ; Spectrum Analysis